["{\"step_by_step_thinking\": \"The question states that topical administration of 1% Pilocarpine failed to produce pupillary constriction in a patient with a large, dilated pupil. We need to analyze the effects of pilocarpine on pupil size from the provided documents. In 'Comparative pharmacologic effects of pilocarpine administered to normal subjects by eyedrops or by ocular therapeutic systems', it is mentioned that pilocarpine produced maximal myotic effect (pupillary constriction) in normotensive beagles at 2% concentration, and at 1% concentration, the maximum reduction was 25%. In 'The effect of topical pilocarpine on intraocular pressure and pupil size in the normotensive and glaucomatous beagle', it is stated that 1% pilocarpine produced a maximal decrease of pupillary size of 25%. Given these findings, we can infer that 1% pilocarpine should typically cause some degree of pupillary constriction. However, in the given patient, this did not occur, suggesting an underlying abnormality that prevents the typical response to pilocarpine., \"answer_choice\": \"A\"}"]